Opportunities For Pharmaceutical Companies

Screen, identify and understand the effect of drugs on the microbiome and the effect of the microbiome on your drugs

Background frise 3.png

All samples are characterized (qPCR)

Background frise 3.png

Standard cultivation of HUMAN microbiome

96 Well_edited.png

Selected microbiome

Candidate 1

Candidate 2

Candidate 3 ...

Background frise 3.png

Analytic and bioinformatic platform

Final Circle for Handy 05.02.22 without white.png

The combination of an in-house Human Microbiome Sample Bank, a standardized in vitro Human Microbiome Cultivation System and our Multi-Omic and Functional Platform provides a unique all in one solution to discover, screen and understand

=> your product’s impact on the human microbiome and on human health.

=> the impact of the microbiome on your product, drug or foods. 

The gut microbiome is a main target for the development of new drugs.

  • Use our unique all in one in vitro human gut microbiome platform

    • for fast, specific and reliable screening of candidates with positive effect on the composition and the function of the human microbiome.

    • to get a deep understanding of the effect of your product(s) on the human microbiome and get valuable insights into human health.

The bidirectional drug-microbiome interaction may positively or negatively impact the efficacy and/or toxicity of orally applied pharmaceuticals.

  • Use our unique all in one in vitro human gut microbiome platform

    • to discover and understand the impact of the microbiome on your drug(s) candidate(s).

    • to discover and understand the impact of the products resulting from the microbiome metabolization/modification of your products and the related effects on human health.

Depending on their microbiome status, patients may be more or less responsive to specific drug(s) or treatments.

  • Use our unique platform and experience to discover and introduce microbiome related patient stratifying to optimize the outcome of clinical studies